(Q44401076)

2 December 2017

Bone remodeling markers in the detection of bone metastases in prostate cancer (English)

1 reference

2 December 2017

1 reference

https://api.crossref.org/works/10.1016/S0009-8981(03)00081-0

23 December 2023

author name string

Concepción de la Piedra

1

1 reference

2 December 2017

Nilda-Adriana Castro-Errecaborde

2

1 reference

2 December 2017

Maria Luisa Traba

3

1 reference

2 December 2017

Cioly Méndez-Dávila

4

1 reference

2 December 2017

Carmen García-Moreno

5

1 reference

2 December 2017

Lucrecia Rodriguez de Acuña

6

1 reference

2 December 2017

Jesus Rodriguez-Molina

7

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691863

23 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0009898103000810?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0009-8981(03)00081-0

https://api.elsevier.com/content/article/PII:S0009898103000810?httpAccept=text/plain

23 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0009-8981(03)00081-0

23 December 2023

1 reference

2 December 2017

331

1 reference

2 December 2017

45-53

1 reference

2 December 2017

1-2

1 reference

The clinical usefulness of prostate specific antigen: update 1994.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

A reappraisal of serial isotope bone scans in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Molecular markers of bone turnover: biochemical, technical and analytical aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Biochemical markers of bone formation in the study of postmenopausal osteoporosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900081-0

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference